Samuel N. Hazen - 29 Jan 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
CEO, Director
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
29 Jan 2026
Net transactions value
-$13,340,759
Form type
4
Filing time
02 Feb 2026, 18:49:00 UTC
Previous filing
18 Nov 2025
Next filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAZEN SAMUEL N CEO, Director ONE PARK PLAZA, NASHVILLE /s/ Kevin A. Ball, Attorney-in-Fact 02 Feb 2026 0001216838

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $6,914,146 +84,360 +261% $81.96 116,636 30 Jan 2026 Direct
transaction HCA Common Stock Tax liability $20,254,904 -41,483 -36% $488.27 75,153 30 Jan 2026 Direct
holding HCA Common Stock 14,979 29 Jan 2026 By HD Trust
holding HCA Common Stock 16,731 29 Jan 2026 By 2023 GST Trust
holding HCA Common Stock 93,088 29 Jan 2026 By 2023 Trust
holding HCA Common Stock 178,289 29 Jan 2026 By 2024 GRAT
holding HCA Common Stock 200,000 29 Jan 2026 By 2025 GRAT
holding HCA Common Stock 813,320 29 Jan 2026 By LP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +55,846 $0.000000 55,846 29 Jan 2026 Common Stock 55,846 $482.53 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -84,360 -100% $0.000000 0 30 Jan 2026 Common Stock 84,360 $81.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.